Literature DB >> 12630921

Effects of the Japanese herbal medicine Keishi-bukuryo-gan and 17beta-estradiol on calcitonin gene-related peptide-induced elevation of skin temperature in ovariectomized rats.

M Noguchi1, Y Ikarashi, M Yuzurihara, Y Kase, J-T Chen, S Takeda, M Aburada, A Ishige.   

Abstract

The effects of a Japanese herbal medicine, Keishi-bukuryo-gan, and 17beta-estradiol on calcitonin gene-related peptide (CGRP)-induced elevation of skin temperature were investigated in ovariectomized (OVX) rats. Ovariectomy not only potentiated CGRP-induced elevation of skin temperature and arterial vasorelaxation but also induced a lower concentration of endogenous CGRP in plasma and up-regulation of arterial CGRP receptors, suggesting that lowered CGRP in plasma due to ovarian hormone deficiency increases the number of CGRP receptors and consequently amplifies the stimulatory effects of CGRP to elevate skin temperature. Oral Keishi-bukuryo-gan (100-1000 mg/kg, once a day for 7 days) restored a series of CGRP-related responses observed in OVX rats by normalizing plasma CGRP levels in a dose-dependent manner as effectively as s.c. injection. 17Beta-estradiol (0.010 mg/kg, once a day for 7 days). However, Keishi-bukuryo-gan did not affect the lower concentration of plasma estradiol and the decreased uterine weight due to ovariectomy, although the hormone replacement of 17beta-estradiol restored them. These results suggest that Keishi-bukuryo-gan, which does not confer estrogen activity on plasma, may be useful for the treatment of hot flashes in patients for whom estrogen replacement therapy is contraindicated, as well as menopausal women.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12630921     DOI: 10.1677/joe.0.1760359

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  7 in total

Review 1.  What has been overlooked on study of Chinese materia medica in the West?

Authors:  Willow J H Liu
Journal:  Chin J Integr Med       Date:  2015-07-09       Impact factor: 1.978

2.  The TU-025 keishibukuryogan clinical trial for hot flash management in postmenopausal women: results and lessons for future research.

Authors:  Gregory A Plotnikoff; Kenji Watanabe; Carolyn Torkelson; June La Valleur; David M Radosevich
Journal:  Menopause       Date:  2011-08       Impact factor: 2.953

3.  Identification of a predictive biomarker for the beneficial effect of keishibukuryogan, a kampo (Japanese traditional) medicine, on patients with climacteric syndrome.

Authors:  Takao Namiki; Hiromi Sato; Yukari Matsumoto; Haruka Kakikura; Koichi Ueno; Atsushi Chino; Hideki Okamoto; Akito Hisanaga; Akiyo Kaneko; Toshiaki Kita; Maki Kihara; Makio Shozu; Katsutoshi Terasawa
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-20       Impact factor: 2.629

Review 4.  A Classic Herbal Formula Guizhi Fuling Wan for Menopausal Hot Flushes: From Experimental Findings to Clinical Applications.

Authors:  Mingdi Li; Andrew Hung; Hong Li; Angela Wei Hong Yang
Journal:  Biomedicines       Date:  2019-08-18

Review 5.  A Review on the Mechanism and Application of Keishibukuryogan.

Authors:  Koichiro Tanaka; Koki Chiba; Kazuhiko Nara
Journal:  Front Nutr       Date:  2021-12-24

6.  Keishibukuryogan is not carcinogenic in Sprague-Dawley rats.

Authors:  Masanao Kanitani; Nobuo Nishimura; Hiroshi Edamoto; Yoshio Kase
Journal:  J Toxicol Pathol       Date:  2016-02-12       Impact factor: 1.628

7.  Immunological efficacy of herbal medicines in prostate cancer patients treated by personalized peptide vaccine.

Authors:  Noriko Koga; Fukuko Moriya; Kayoko Waki; Akira Yamada; Kyogo Itoh; Masanori Noguchi
Journal:  Cancer Sci       Date:  2017-10-03       Impact factor: 6.716

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.